Skip to main content

Advertisement

Log in

IgM Monoclonal Gammopathy in Gastric MALToma

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361–92.

    CAS  PubMed  Google Scholar 

  2. Berger F, Traverse-Glehen A, Felman P, Callet-Bauchu E, Baseggio L, Gazzo S, et al. Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity? Clin Lymphoma. 2005;5(4):220–4.

    Article  PubMed  Google Scholar 

  3. Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G, et al. Updated Kiel classification for lymphomas. Lancet. 1988;1(8580):292–3.

    Article  CAS  PubMed  Google Scholar 

  4. Jaffe E, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001.

    Google Scholar 

  5. Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003;30(2):110–5.

    Article  PubMed  Google Scholar 

  6. Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.

    Google Scholar 

  7. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, The JES. WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2008;117(19):5019–32.

    Article  Google Scholar 

  8. Griesser H, Kaiser U, Augener W, Tiemann M, Lennert K. B-cell lymphoma of the mucosa-associated lymphatic tissue (MALT) presenting with bone marrow and peripheral blood involvement. Leuk Res. 1990;14(7):617–22.

    Article  CAS  PubMed  Google Scholar 

  9. Allez M, Mariette X, Linares G, Bertheau P, Jian R, Brouet JC. Low-grade MALT lymphoma mimicking Waldenstrom's macroglobulinemia. Leukemia. 1999;13(3):484–5.

    Article  CAS  PubMed  Google Scholar 

  10. Valdez R, Finn WG, Ross CW, Singleton TP, Tworek JA, Schnitzer B. Waldenstrom macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases. Am J Clin Pathol. 2001;116(5):683–90.

    Article  CAS  PubMed  Google Scholar 

  11. Salle V, Smail A, Joly JP, Capiod JC, Gontier MF, Duhaut P, et al. Gastric MALT lymphoma presenting as Waldenstrom's macroglobulinemia without bone marrow involvement. Clin Lymphoma Myeloma. 2007;7(7):470–1.

    Article  CAS  PubMed  Google Scholar 

  12. Wohrer S, Streubel B, Bartsch R, Chott A, Raderer M. Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res. 2004;10(21):7179–81.

    Article  PubMed  Google Scholar 

  13. Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2005;23(21):4643–51.

    Article  PubMed  Google Scholar 

  14. Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol. 2005;16(3):473–80.

    Article  CAS  PubMed  Google Scholar 

  15. Alinari L, Castellucci P, Elstrom R, Ambrosini V, Stefoni V, Nanni C, et al. 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma. 2006;47(10):2096–101.

    Article  CAS  PubMed  Google Scholar 

  16. Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, et al. Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma. Eur J Haematol. 2007;79(3):205–9.

    Article  PubMed  Google Scholar 

  17. Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2012;61(4):507–13.

    Article  PubMed  Google Scholar 

  18. Wundisch T, Thiede C, Morgner A, Dempfle A, Gunther A, Liu H, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005;23(31):8018–24.

    Article  PubMed  Google Scholar 

  19. Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999;131(2):88–95.

    Article  CAS  PubMed  Google Scholar 

  20. Park HS, Kim YJ, Yang WI, Suh CO, Lee YC. Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma. World J Gastroenterol. 2010;16(17):2158–62.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998;16(5):1916–21.

    CAS  PubMed  Google Scholar 

  22. Hitchcock S, Ng AK, Fisher DC, Silver B, Bernardo MP, Dorfman DM, et al. Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2002;52(4):1058–66.

    Article  PubMed  Google Scholar 

  23. Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21(22):4157–64.

    Article  PubMed  Google Scholar 

  24. Koch P, Probst A, Berdel WE, Willich NA, Reinartz G, Brockmann J, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 2005;23(28):7050–9.

    Article  PubMed  Google Scholar 

  25. Martinelli G, Laszlo D, Ferreri AJ, Pruneri G, Ponzoni M, Conconi A, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol. 2005;23(9):1979–83.

    Article  CAS  PubMed  Google Scholar 

  26. Hammel P, Haioun C, Chaumette MT, Gaulard P, Divine M, Reyes F, et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol. 1995;13(10):2524–9.

    CAS  PubMed  Google Scholar 

  27. Jager G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol. 2002;20(18):3872–7.

    Article  PubMed  Google Scholar 

  28. Salar A, Domingo-Domenech E, Estany C, Canales MA, Gallardo F, Servitje O, et al. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Cancer. 2009;115(22):5210–7.

    Article  CAS  PubMed  Google Scholar 

  29. Brown JR, Friedberg JW, Feng Y, Scofield S, Phillips K, Dal Cin P, et al. A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. Br J Haematol. 2009;145(6):741–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Zucca E, Conconi A, Martinelli G, Martelli M, Thieblemont C, Johnson PW, Lopez-Guillermo A, Bouabdallah R et al. (2010) Chlorambucil plus rituximab produces better event-free survival in comparison with chlorambucil alone in the treatment of MALT Lymphoma: 5-year analysis of the 2-arms part of the IELSG-19 randomized study. In: ASH Annual Meeting Abstracts. Orange County Convention Center, Orlando, 4–7 Dec 2010 116:432

  31. Conconi A, Martinelli G, Lopez-Guillermo A, Zinzani PL, Ferreri AJ, Rigacci L, Devizzi L, Vitolo U, Luminari S, Cavalli F, Zucca E. Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). Ann Oncol 2011;22 (3):689–695

    Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhineng J. Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, Z.J., Sandhu, G.S., Aggarwal, N. et al. IgM Monoclonal Gammopathy in Gastric MALToma. J Gastrointest Canc 45, 91–95 (2014). https://doi.org/10.1007/s12029-013-9483-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-013-9483-9

Keywords

Navigation